# Pulmonary Rehab in Chronic Obstructive Pulmonary Disease (COPD): Response to Tyvaso

> **NCT02178566** · PHASE2 · TERMINATED · sponsor: **Inova Health Care Services** · enrollment: 1 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** Inhaled Treprostinil

## Key facts

- **NCT ID:** NCT02178566
- **Lead sponsor:** Inova Health Care Services
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-08
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Unable to enroll
- **Last updated:** 2022-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02178566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02178566, "Pulmonary Rehab in Chronic Obstructive Pulmonary Disease (COPD): Response to Tyvaso". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02178566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*